Cronos Group (CRON) Investor Settlement
Cronos Group has reached a settlement with $CRON investors over claims it inflated revenue through sham cannabis sales and hid major financial reporting weaknesses in 2019.
Outline
In 2019, Cronos reported strong revenue growth. But the company later restated its earnings after revealing that it had recorded non-existent sales from “round-trip” cannabis transactions. $CRON fell nearly 50% as the fraud came to light, and regulators launched investigations. After that, Cronos faced a lawsuit from investors.
Timeline
May 9, 2019 – Cronos reported Q1 revenue that included C$2.5M in sales.
September 19, 2019 – An additional sale was booked with MediPharm, inflating Q3 revenue by C$3M.
February 24, 2020 – Cronos delayed its earnings release; $CRON fell 10.9%.
March 2, 2020 – The company filed an incomplete annual report; stock dropped 11.6%.
March 11, 2020 – Investors filed a lawsuit against Cronos.
March 30, 2020 – Cronos filed restatements for Q1 and Q3 2019 with internal control failures disclosed; $CRON dropped another 29%.
October 24, 2022 – The SEC and OSC charged Cronos and former executives with accounting fraud.
May 30, 2025 – Cronos agreed to settle the claims.
Background
Cronos, a Canadian cannabis company, promoted itself as a leader in both medical and recreational cannabis markets. In 2019, it reported substantial revenue growth through deals with MediPharm and Heritage Cannabis.
But behind the scenes, Cronos recorded processing transactions as sales, falsely boosting revenue in at least two quarters.
In these round-trip arrangements, Cronos sent cannabis to be processed and then reacquired the product, yet booked the initial transfer as a sale.
These actions were later exposed, prompting earnings restatements for Q1 and Q3 2019, totaling a CAD $7.6 million reduction in revenue. The company also admitted internal control failures, and its auditor, KPMG, declined reappointment.
After all of this happened, in March 2020, shareholders sued the company for misleading them about its financial performance.
In 2022, U.S. and Canadian regulators charged Cronos and its former Chief Commercial Officer with accounting fraud.
Following the restatements and enforcement actions, $CRON dropped nearly 50% from its previous highs.
What Can Investors Expect Now?
Cronos Group has reached a settlement with $CRON investors over claims it inflated revenue through sham cannabis sales and hid major financial reporting weaknesses in 2019.
If you were damaged due to this situation, you can file for a payout and get your share of the settlement. You can check if you are eligible and other details in the FAQ section below.
Frequently Asked Questions
All persons and entities who purchased or otherwise acquired the publicly traded securities of Cronos on a U.S. Stock Exchange between May 9, 2019 and March 30, 2020, inclusive, and were damaged thereby.
No, if you have purchased securities within the class period, you are eligible to participate.
You can participate in the settlement and retain (or sell) your securities.
The entire process usually takes 4 to 9 months after the claim deadline. But the exact timing depends on the court and settlement administration.
If you're eligible, you can file your claim directly from this case page by clicking the "Collect Payout" button.
More than 100 companies are currently paying out settlements. Connect your brokerage account to automatically check which ones you may have missed — or file manually for this case.
11th.com is an investor recovery company that helps investors track and collect securities class action settlements. We will:
1. Prepare documents for your payout.
2. Audit the claim and make sure you get the maximum possible payout.
3. File a claim with the settlement administration.
4. Correspond with the settlement administration to resolve emerging issues.
5. Deliver payout directly to your brokerage account.
There is no upfront cost, but we will deduct 20% of the recovered amount as a commission for our services.